Safety of immunogenicity of Haemophilus influenzae type b conjugate vaccine (PedvaxHIB™) in Papua New Guinean children

Papua and New Guinea Medical Journal

Volumn , Issue 34, 1998, Pages 102-111

  Lehmann, Deborah ^a,b   Kakazo, Mexy ^a   Yarsley, Sarah ^a   Javati, Agnes ^a   Taime, John ^a   Saleu, Gerard ^a   Namuigi, Pioto ^a   Alpers, Michael P ^a   Mendelman, Paul M ^c,d   Staub, Ted ^c  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MERCK RESEARCH LABORATORIES   (United States)

^d MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL POLYSACCHARIDE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE NEISSERIA MENINGITIDIS OUTER MEMBRANE PROTEIN CONJUGATE VACCINE; HAEMOPHILUS INFLUENZAE-TYPE B POLYSACCHARIDE-NEISSERIA MENINGITIDIS OUTER MEMBRANE PROTEIN CONJUGATE VACCINE; HAEMOPHILUS VACCINE; OUTER MEMBRANE PROTEIN; VACCINE;

ARTICLE; EVALUATION; FEMALE; HUMAN; INFANT; MALE; NEWBORN; PAPUA NEW GUINEA; PREVENTIVE HEALTH SERVICE;

BACTERIAL OUTER MEMBRANE PROTEINS; EVALUATION STUDIES; FEMALE; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MALE; PAPUA NEW GUINEA; POLYSACCHARIDES, BACTERIAL; VACCINES, CONJUGATE;

EID: 0032148775     PISSN: 00311480     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Garenne M, Ronsmans C, Campbell H. The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries. World Health Stat Q 1992;45:180-191.
2. Berman S. Epidemiology of acute respiratory infections in children of developing countries. Rev Infect Dis 1991;13(Suppl 6):S454-S462.
3. Papua New Guinea Department of Health. National Health Plan 1996 - 2000. Port Moresby: Department of Health, 1996.
4. Lehmann D. Epidemiology of acute respiratory infections, especially those due to Haemophilus influenzae, in Papua New Guinean children. J Infect Dis 1992;165(Suppl 1):S20-S25.
5. Barker J, Gratten M, Riley ID, Lehmann D, Montgomery J, Kajoi M, Gratten M, Smith D, Marshall TF deC, Alpers MP. Pneumonia in children in the Eastern Highlands of Papua New Guinea: a bacteriologic study in patients selected by standard clinical criteria. J Infect Dis 1989;159:348-352.
6. Gratten M, Barker J, Shann F, Gerega G, Montgomery J, Kajoi M, Lupiwa T. The aetiology of purulent meningitis in highland children: a bacteriological study. PNG Med J 1985;28:233-240.
7. Funkhouser A, Steinhoff MC, Ward J. Haemophilus influenzae disease and immunization in developing countries. Rev Infect Dis 1991:13(Suppl 6):S542-S554.
8. Lehmann D, Yeka W, Rongap T, Javati A, Saleu G, Clegg A, Michael A, Lupiwa T, Omena M, Alpers MP. Aetiology and clinical signs of bacterial meningitis in children admitted to Goroka Base Hospital, Papua New Guinea, 1989-1992. Ann Trop Paediatr 1999;19:in press.
9. Hanna JN. The epidemiology of invasive Haemophilus influenzae infections in children under five years of age in the Northern Territory: a three-year study. Med J Aust 1990;152:234-240.
10. Eskola J, Käyhty H, Takala AK, Peltola H, Rönnberg PR, Kela E, Pekkanen E, McVerry PH, Mäkelä PH. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med 1990;323:1381-1387.
11. Santosham M, Wolff M, Reid R, Hohenboken M, Bateman M, Goepp J, Cortese M, Sack D, Hill J, Newcomer W. The efficacy in Navajo infants of conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324:1767-1772.
12. Black SB, Shinefield HS, Fireman B, Hiatt R, Polen M, Vittinghoff E. Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr Infect Dis J 1991;10:97-104.
13. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, Weber M, Palmer A, Schneider G, Jobe K, Lahai G, Jaffar S, Secka O, Lin K, Ethévenaux C, Greenwood B. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-1197.
14. Harrison LH, Tajkowski C, Croll J, Reid R, Hu D, Brenneman G, Weatherholtz RC, Santosham M. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children. J Pediatr 1994;125:571-576.
15. Lagos R, Horwitz I, Toro J, San Martin O, Abrego P, Bustamante C, Wasserman SS, Levine OS, Levine MM. Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzas type b infections. Pediatr Infect Dis J 1996;15:216-222.
16. Herceg A. The decline of Haemophilus influenzae type b disease in Australia. Commun Dis Intell 1997;21:173-176.
17. Takala AK, Eskola J, Leinonen M, Käyhty H, Nissinen A, Pekkanen E, Mäkelä PH. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-986.
18. Takala AK, Santosham M, Almeido-Hill J, Wolff M, Newcomer W, Reid R, Käyhty H, Esko E, Mäkelä PH. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 1993;12:593-599.
19. Michael A, Combs B, Gratten M, Montgomery J, Lupiwa T, Mgone J, Lebmann D. Emergence of multiresistant Haemophilus influenzae type b in Papua New Guinea. Abstract in Program and Abstracts of the International Conference on Acute Respiratory Infections, Canberra, 7-10 Jul 1997:81.
20. Papua New Guinea Department of Health. Standard Treatment of Common Illnesses of Children in Papua New Guinea. A Manual for Nurses, Health Extension Officers and Doctors, 6th edition. Port Moresby: Department of Health, 1993.
21. Ward JI, Greenberg DP, Anderson PW, Burkart KS, Christenson PD, Gordon LK, Käyhty H, Kuo JSC, Vella P. Variable quantitation of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. J Clin Microbiol 1988;26:72-78.
22. Dean AG, Dean JA, Coulombier D, Brendel KA. Epi Info, version 6: a Word Processing, Database, and Statistics Program for Epidemiology on Microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1994.
23. Käyhty H, Peltola H, Karanko V, Mäkelä PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
24. Santosham M, Hill J, Wolff M, Reid R, Lukacs L, Ahonkhai V. Safety and immunogenicity of a Haemophilus influenzae type b conjugate vaccine in a high risk American Indian population. Pediatr Infect Dis J 1991;10:113-117.
25. Bulkow LR, Wainwright RB, Letson GW, Chang SJ, Ward JI. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaskan Native infants. Pediatr Infect Dis J 1993;12:484-492.
26. Campbell H, Byass P, Ahonkhai VI, Vella PP, Greenwood BM. Serologic responses to an Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants. Pediatrics 1990;86:102-107.
27. Montgomery JM, Lehmann D, Smith T, Michael A, Joseph B, Lupiwa T, Coakley C, Spooner V, Best B, Riley ID, Alpers MP. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in highland children of Papua New Guinea. Rev Infect Dis 1990;12(Suppl 8):S1006-S1016.
28. Calandra GB, Lukacs LJ, Jonas LC, Santosham M, Ward JI, Greenberg DP, Daum RS, Matthews H, Vella PP, Ryan JL. Anti-PRP antibody levels after a primary series of PRP-OMPC and persistence of antibody titres following primary and booster doses. Vaccine 1993;11(Suppl 1):S58-S62.
29. National Health and Medical Research Council. The Australian Immunisation Handbook, 6th edition. Canberra: Australian Government Publishing Service, 1997:102-109.
30. Mulholland EK, Hoestermann A, Ward JI, Maine N, Ethévenaux C, Greenwood BM. The use of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine mixed with diphtheria-tetanus-pertussis vaccine in Gambian infants. Vaccine 1996;14:905-909.
31. Capeding MRZ, Nohynek H, Pascual LG, Käyhty H, Sombrero LT, Eskola J, Ruutu P. The immunogenicity of three Haemophilus influenzae type b conjugate vaccines after a primary vaccination series in Philippine infants. Am J Trop Med Hyg 1996;55:516-520.
32. Mulholland EK, Todd J, Rowe M, Campbell H, Byass P, Vella PP, Ahonkhai VI, Greenwood BM. Persistence of antibody at 18 months following vaccination of young Gambian infants with PRP-OMPC Haemophilus influenzae type b conjugate vaccine. Ann Trop Paediatr 1993;13:153-158.